National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children

Author:

Powell Annabel A.,Ireland Georgina,Leeson Rebecca,Lacey Andrea,Ford Ben,Poh John,Ijaz Samreen,Shute Justin,Cherepanov Peter,Tedder Richard,Bottomley Christian,Dawe Fiona,Mangtani Punam,Jones Peter,Nguipdop-Djomo Patrick,Ladhani Shamez N.,Ahmad Shazaad,Baawuah Frances,Beckmann Joanne,Brent Andrew,Brent Bernadette,Garstang Joanna,Okike Ifeanyichukwu O.,Brown Kevin,Ramsay Mary,Bonell Chris,Cook Sarah,Warren-Gash Charlotte,Phelan Jody,Hargreaves James,Langan Sinead,Sundaram Neisha,McClenaghan Elliot,McKay Gillian,Edmunds John,Fine Paul

Funder

Department of Health and Social Care

Wellcome Trust

Cancer Research UK

Francis Crick Institute

Medical Research Council

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference34 articles.

1. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis;Viner;JAMA Pediatr,2021

2. Transmission of SARS-CoV-2 by children and young people in households and schools: ameta-analysis of population-based and contact-tracing studies;Viner;J Infect,2022

3. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection;Dowell;Nature Immunol,2022

4. COVID-19 vaccination in children and young people aged 16 to 17 years: JCVI statement, November 2021 [press release]. 15th November 2021.

5. Department of Health and Social Care. JCVI statement on COVID-19 vaccination of children aged 12 to 15 years: 3 September 2021 2021. Available from: 〈https://www.gov.uk/government/publications/jcvi-statement-september-2021-covid-19-vaccination-of-children-aged-12-to-15-years/jcvi-statement-on-covid-19-vaccination-of-children-aged-12-to-15-years-3-september-2021#annex-a-jcvi-advice-on-vaccination-of-children-aged-12-to-15-years-with-underlying-health-conditions-31-august-2021〉.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3